Skip to main content
VRCA logo

VRCA · Verrica Pharmaceuticals Inc. · Investor Relations

Track VRCA — free
$3.56 -0.16 (-4.30%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$61.16M
Shares
17.18M
Volume · Nov 13 18.68K Avg daily vol (3M) 72.22K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-19 13:30 UTC Jefferies Global Healthcare Conference in London Conference

Recent news

Past events

Date Event Type
2026-11-12 Verrica Pharmaceuticals Inc. Q3 FY2026 Earnings Call Earnings call
2026-10-15 2026 PeDRA Annual Conference Conference
2026-09-14 September 14, 2026 Event
2026-08-19 August 19, 2026 Event
2026-08-06 Q2 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-06-04 Thursday, June 4, 2026 (11:05 am ET) Webcast
2026-05-19 Tuesday, May 19, 2026 (1:30pm ET) Webcast
2026-05-15 Friday, May 15, 2026 at 4:30 pm – 6:00 pm – Poster Number: LB1190 – VP-315 Demonstrates Potential Abscopal Effect in Untreated Non-Target Basal Cell Carcinoma (BCC) Tumors Event
2026-05-15 2026 Society for Investigative Dermatology (SID) Annual Meeting Event
2026-05-13 May 13, 2026 Event
2026-05-12 Tuesday, May 12, 2026 (4:30 pm ET) Event
2026-05-12 Q1 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-03-11 Earnings conference call (announced in 8-K) Earnings call

Source: https://verrica.com/investor-connection/

Key facts CIK 1660334 CUSIP 92511W207 13F (30d) 46 filings 25 filers Visit website Investor relations